Home Healthcare Biotechnology Autologous Cell Therapy Market

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Cell Type (Hematopoietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), Chondrocytes, Fibroblasts, Keratinocytes, Other Autologous Cells), By Source (Epidermis, Bone Marrow, Mesenchymal Stem Cells, Haematopoietic Stem Cells, Chondrocytes, Others), By Application (Cancer, Cardiovascular Disorders, Neurodegenerative Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), By End-User (Hospitals & Clinics, Ambulatory Centers, Academics & Research, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
  7. North America Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
  8. Europe Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
  9. APAC Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
  10. Middle East and Africa Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
  11. LATAM Autologous Cell Therapy Market Size Analysis
    1. Introduction
    2. Autologous Cell Therapy Market Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
      1. Hematopoietic Stem Cells (HSCs)
      2. Mesenchymal Stem Cells (MSCs)
      3. Chondrocytes
      4. Fibroblasts
      5. Keratinocytes
      6. Other Autologous Cells
    3. Autologous Cell Therapy Market Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
      1. Epidermis
      2. Bone Marrow
      3. Mesenchymal Stem Cells
      4. Haematopoietic Stem Cells
      5. Chondrocytes
      6. Others
    4. Autologous Cell Therapy Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cardiovascular Disorders
      3. Neurodegenerative Disorders
      4. Autoimmune Disorders
      5. Orthopedics
      6. Wound Healing
      7. Others
    5. Autologous Cell Therapy Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Cell Type 2022-2034 (USD MILLION/ Units)
        1. Hematopoietic Stem Cells (HSCs)
        2. Mesenchymal Stem Cells (MSCs)
        3. Chondrocytes
        4. Fibroblasts
        5. Keratinocytes
        6. Other Autologous Cells
      3. Market Size & Forecast By Source 2022-2034 (USD MILLION/ Units)
        1. Epidermis
        2. Bone Marrow
        3. Mesenchymal Stem Cells
        4. Haematopoietic Stem Cells
        5. Chondrocytes
        6. Others
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Disorders
        3. Neurodegenerative Disorders
        4. Autoimmune Disorders
        5. Orthopedics
        6. Wound Healing
        7. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
  12. Competitive Landscape
    1. Autologous Cell Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Vericel Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. BrainStorm Cell Therapeutics Inc.
    3. Holostem Terapie Avanzate S.r.l.
    4. Takeda Pharmaceutical Company Limited
    5. DON AG
    6. BioTime, Inc. (now Lineage Cell Therapeutics)
    7. Castle Creek Biosciences, Inc.
    8. Iovance Biotherapeutics, Inc.
    9. Regeneus Ltd
    10. Celgene Corporation (a Bristol-Myers Squibb company)
    11. Novartis AG
    12. Pharmicell Co., Ltd.
    13. Medipost Co., Ltd.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.